Virus-specific T-cell immunity correlates with control of GB virus B infection in marmosets

Journal of Virology

Volumn 82, Issue 6, 2008, Pages 3054-3060

  Woollard, David J ^a,b   Haqshenas, Gholamreza ^a,c   Dong, Xuebin ^a,c   Pratt, Bridget F ^d   Kent, Stephen J ^d   Gowans, Eric J ^a,c  

^a BURNET INSTITUTE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 4A; NONSTRUCTURAL PROTEIN 5B;

ACUTE HEPATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD; CELLULAR IMMUNITY; DISEASE COURSE; ENZYME LINKED IMMUNOSPOT ASSAY; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; INFECTION CONTROL; LIVER; MARMOSET; NONHUMAN; PRIORITY JOURNAL; REINFECTION; T LYMPHOCYTE; VIREMIA; VIRUS INFECTION;

AMINO ACID SEQUENCE; ANIMALS; CALLITHRIX; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GB VIRUS B; HEPATITIS, VIRAL, ANIMAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; MOLECULAR SEQUENCE DATA; T-LYMPHOCYTES;

ANIMALIA; CALLITRICHIDAE; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B;

EID: 40149108604     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01153-07     Document Type: Article

References (33)

1. Antunes, S. G., N. G. de Groot, H. Brok, G. Doxiadis, A. A. Menezes, N. Otting, and R. E. Bontrop. 1998. The common marmoset: a new world primate species with limited MHC class II variability. Proc. Natl. Acad. Sci. USA 95:11745-11750.
2. Bassett, S. E., B. Guerra, K. Brasky, E. Miskovsky, M. Houghton, G. R. Klimpel, and R. E. Lanford. 2001. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479-1487.
3. Beames, B., D. Chavez, B. Guerra, L. Notvall, K. M. Brasky, and R. E. Lanford. 2000. Development of a primary tamarin hepatocyte culture system for GB virus-B: a surrogate model for hepatitis C virus. J. Virol. 74:11764-11772.
4. Bright, H., A. R. Carroll, P. A. Watts, and R. J. Fenton. 2004. Development of a GB virus B marmoset model and its validation with a novel series of hepatitis C virus NS3 protease inhibitors. J. Virol. 78:2062-2071.
5. Bukh, J., C. L. Apgar, and M. Yanagi. 1999. Toward a surrogate model for hepatitis C virus: an infectious molecular clone of the GB virus-B hepatitis agent. Virology 262:470-478.
6. Butkiewicz, N., N. Yao, W. Zhong, J. Wright-Minogue, P. Ingravallo, R. Zhang, J. Durkin, D. N. Standring, B. M. Baroudy, D. V. Sangar, S. M. Lemon, J. Y. Lau, and Z. Hong. 2000. Virus-specific cofactor requirement and chimeric hepatitis C virus/GB virus B nonstructural protein 3. J. Virol. 74:4291-4301.
7. Chang, K. M., R. Thimme, J. J. Melpolder, D. Oldach, J. Pemberton, J. Moorhead-Loudis, J. G. McHutchison, H. J. Alter, and F. V. Chisari. 2001. Differential CD4(+) and CD8(+) T-cell responsiveness in hepatitis C virus infection. Hepatology 33:267-276.
8. Chen, Z., Y. Benureau, R. Rijnbrand, J. Yi, T. Wang, L. Warter, R. E. Lanford, S. A. Weinman, S. M. Lemon, A. Martin, and K. Li. 2007. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J. Virol. 81:964-976.
9. Cooper, S., A. L. Erickson, E. J. Adams, J. Kansopon, A. J. Weiner, D. Y. Chien, M. Houghton, P. Parham, and C. M. Walker. 1999. Analysis of a successful immune response against hepatitis C virus. Immunity 10:439-449.
10. + T-helper-cell responses in resolved hepatitis C virus infection. J. Virol. 76:12584-12595.
11. Farci, P., H. J. Alter, D. C. Wong, R. H. Miller, S. Govindarajan, R. Engle, M. Shapiro, and R. H. Purcell. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc. Natl. Acad. Sci. USA 91:7792-7796.
12. Folgori, A., S. Capone, L. Ruggeri, A. Meola, E. Sporeno, B. B. Ercole, M. Pezzanera, R. Tafi, M. Arcuri, E. Fattori, A. Lahm, A. Luzzago, A. Vitelli, S. Colloca, R. Cortese, and A. Nicosia. 2006. A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees. Nat. Med. 12:190-197.
13. Grabowska, A. M., F. Lechner, P. Klenerman, P. J. Tighe, S. Ryder, J. K. Ball, B. J. Thomson, W. L. Irving, and R. A. Robins. 2001. Direct ex vivo comparison of the breadth and specificity of the T cells in the liver and peripheral blood of patients with chronic HCV infection. Eur. J. Immunol. 31:2388-2394.
14. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662.
15. Haqshenas, G., X. Dong, H. Netter, J. Torresi, and E. J. Gowans. 2007. A chimeric GB virus B encoding the hepatitis C virus hypervariable region 1 is infectious in vivo. J. Gen. Virol. 88:895-902.
16. He, X. S., B. Rehermann, F. X. Lopez-Labrador, J. Boisvert, R. Cheung, J. Mumm, H. Wedemeyer, M. Berenguer, T. L. Wright, M. M. Davis, and H. B. Greenberg. 1999. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers. Proc. Natl. Acad. Sci. USA 96:5692-5697.
17. Houghton, M. 2000. Strategies and prospects for vaccination against the hepatitis C viruses. Curr. Top. Microbiol. Immunol. 242:327-339.
18. Krawczynski, K., M. J. Alter, D. L. Tankersley, M. Beach, B. H. Robertson, S. Lambert, G. Kuo, J. E. Spelbring, E. Meeks, S. Sinha, and D. A. Carson. 1996. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J. Infect. Dis. 173:822-828.
19. Lanford, R. E., D. Chavez, L. Notvall, and K. M. Brasky. 2003. Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia. Virology 311:72-80.
20. Lechner, F., D. K. Wong, P. R. Dunbar, R. Chapman, R. T. Chung, P. Dohrenwend, G. Robbins, R. Phillips, P. Klenerman, and B. D. Walker. 2000. Analysis of successful immune responses in persons infected with hepatitis C virus. J. Exp. Med. 191:1499-1512.
21. Martin, A., F. Bodola, D. V. Sangar, K. Goettge, V. Popov, R. Rijnbrand, R. E. Lanford, and S. M. Lemon. 2003. Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc. Natl. Acad. Sci. USA 100:9962-9967.
22. Muerhoff, A. S., T. P. Leary, J. N. Simons, T. J. Pilot-Matias, G. J. Dawson, J. C. Erker, M. L. Chalmers, G. G. Schlauder, S. M. Desai, and I. K. Mushahwar. 1995. Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis. J. Virol. 69:5621-5630.
23. Prasad, S., I. Humphreys, S. Kireta, R. B. Gilchrist, P. Bardy, G. R. Russ, and P. T. Coates. 2006. MHC class II DRB genotyping is highly predictive of in-vitro alloreactivity in the common marmoset. J. Immunol. Methods 314:153-163.
24. Pratt, B. F., D. H. O'Connor, B. A. Lafont, J. L. Mankowski, C. S. Fernandez, R. Triastuti, A. G. Brooks, S. J. Kent, and M. Z. Smith. 2006. MHC class I allele frequencies in pigtail macaques of diverse origin. Immunogenetics 58:995-1001.
25. Premkumar, A., X. Dong, G. Haqshenas, P. W. Gage, and E. J. Gowans. 2006. Amantadine inhibits the function of an ion channel encoded by GB virus B, but fails to inhibit virus replication. Antivir. Ther. 11:289-295.
26. Puig, M., K. Mihalik, J. C. Tilton, O. Williams, M. Merchlinsky, M. Connors, S. M. Feinstone, and M. E. Major. 2006. CD4+ immune escape and subsequent T-cell failure following chimpanzee immunization against hepatitis C virus. Hepatology 44:736-745.
27. Sbardellati, A., E. Scarselli, E. Verschoor, A. De Tomassi, D. Lazzaro, and C. Traboni. 2001. Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J. Gen. Virol. 82:2437-2448.
28. Scarselli, E., A. Urbani, A. Sbardellati, L. Tomei, R. De Francesco, and C. Traboni. 1997. GB virus B and hepatitis C virus NS3 serine proteases share substrate specificity. J. Virol. 71:4985-4989.
29. Shoukry, N. H., A. Grakoui, M. Houghton, D. Y. Chien, J. Ghrayeb, K. A. Reimann, and C. M. Walker. 2003. Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197:1645-1655.
30. Smith, M. Z., C. J. Dale, R. De Rose, I. Stratov, C. S. Fernandez, A. G. Brooks, J. Weinfurter, K. Krebs, C. Riek, D. I. Watkins, D. H. O'Connor, and S. J. Kent. 2005. Analysis of pigtail macaque major histocompatibility complex class I molecules presenting immunodominant simian immunodeficiency virus epitopes. J. Virol. 79:684-695.
31. Thimme, R., J. Bukh, H. C. Spangenberg, S. Wieland, J. Pemberton, C. Steiger, S. Govindarajan, R. H. Purcell, and F. V. Chisari. 2002. Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc. Natl. Acad. Sci. USA 99:15661-15668.
32. Ward, S., G. Lauer, R. Isba, B. Walker, and P. Klenerman. 2002. Cellular immune responses against hepatitis C virus: the evidence base 2002. Clin. Exp. Immunol. 128:195-203.
33. Woollard, D. J., A. Grakoui, N. H. Shoukry, K. K. Murthy, K. J. Campbell, and C. M. Walker. 2003. Characterization of HCV-specific Patr class II restricted CD4+ T cell responses in an acutely infected chimpanzee. Hepatology 38:1297-1306.